• About us
• Contact

Advertisement

Organisation › Details

Max Planck Institute for Biochemistry (MPIB) (Martinsried/Munich)

The Max Planck Institute of Biochemistry (MPIB) is an international basic research institute elucidating the structure and function of proteins to better understand cellular mechanisms as well the pathogenesis of diseases such as cancer, diabetes or Alzheimer's as well as to develop new strategies for therapy. With around 850 employees, the Institute is one of the largest biologically-medically oriented research institutes of the Max Planck Society. Since the founding of the Max-Planck-Institute of Biochemistry in 1972, MPIB scientists have twice been awarded the Nobel Prize. The research of the Axel Ullrich lab is especially focused on the molecular analysis of cellular signal transduction mechanisms such as receptor tyrosine kinases and their role in cancer. *

 

	Start	1972-01-01 established
	Group	Max Planck Society for the Advancement of Science
	Industry	BIOTECH
	Person	Ullrich, Axel (Max Planck 201102 Director MPI for Biochemistry, Dept. of Molecular Biology)
	Person 2	Mann, Matthias (Max Planck 200808 MPI for Biochemistry)
	Region	Martinsried
	Country	Germany
	Street	18a Am Klopferspitz
	City	82152 Martinsried
	Tel	+49-89-8578-0
		Address record changed: 2020-12-02
Basic data	Employees	E: 501 to 1,000 (2013-04-22)
		* Document for »About Section«:
		Record changed: 2025-03-16

Advertisement

More documents for Max Planck Society for the Advancement of Science

• [1] Max Planck Innovation GmbH. (12/17/24). "Press Release: Christoph Hüls Becomes Managing Director of Max Planck Innovation GmbH, Succeeding Jörn Erselius, Who Is Retiring after more than 30 Years of Service"....
• [2] Lead Discovery Center GmbH. (10/11/23). "Press Release: LDC and JT Team Up for the Discovery of New Therapies". Dortmund....
• [3] BiondVax Pharmaceuticals Ltd.. (8/11/23). "Press Release: BiondVax Reports Second Quarter Financial Results and Provides Business Update". Jerusalem....
• [4] BiondVax Pharmaceuticals Ltd.. (6/5/23). "Press Release: BiondVax Signs Exclusive License Agreement for Development and Commercialization of a Novel anti-IL-17 Antibody". Jerusalem....
• [5] Max Planck Institute of Biochemsitry. (12/8/22). "Press Release: Karsten Borgwardt Becomes Director at the Max Planck Institute of Biochemistry". Martinsried....
• [6] Bayer AG. (11/10/22). "Press Release: Bayer Acquires German Biotech Start-up Targenomix". Monheim....
• [7] NeoSphere Biotechnologies GmbH. (7/25/22). "Press Release: NeoSphere Biotechnologies Closes Financing Round to Expand Proteomics Platform for Systematic Identification of Novel Targets for Targeted Protein Degradation". Munich....
• [8] Max Planck Society. (5/27/22). "Press Release: Amazon and Max Planck Society Establish Science Hub"....
• [9] Delta 4 GmbH. (9/27/21). "Press Release: Delta4 Announces Dr. Hans Lehrach to Join Scientific Advisory Board". Vienna....
• [10] Draupnir Bio ApS. (9/23/21). "Press Release: Draupnir Bio Establishes Scientific Advisory Board of International Experts in Cholesterol Metabolism and Cardiovascular Disease". Copenhagen....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2025. Made in Germany.